Response Plus Medical, Austability sign strategic partner non-financial MoU

Abu Dhabi, August 18, 2025: Response Plus Medical Services LLC (RPM), a subsidiary of Response Plus Holding PJSC – the largest pre-hospital care and emergency medical services provider in the region, has signed a strategic partner non-financial Memorandum of Understanding (MoU) with Austability Group Ltd, delivering world class expeditionary integrated base operational support services across the globe.

Continue reading Response Plus Medical, Austability sign strategic partner non-financial MoU

du Pay launches ‘Salary in the Digital Wallet’ feature, empowering financial inclusion for the UAE workforce

du Pay highlights commitment to improving customer experience and supporting UAE’s vision of fostering financial inclusivity and innovation.

Dubai, UAE, August 18, 2025 – du Pay, the advanced digital financial services subsidiary of du launches the ‘Salary in the Digital Wallet’ (SITW) feature, a cutting-edge service that allows UAE workforce to receive their salaries directly into their digital du Pay wallets. This feature will enhance the lives of the workforce in the UAE through access to simple, secure, and digital financial services.

Continue reading du Pay launches ‘Salary in the Digital Wallet’ feature, empowering financial inclusion for the UAE workforce

Stonepeak Launches Middle East Renewables Platform WahajPeak

Platform to be led by industry veteran Mothana Qteishat

ABU DHABI & NEW YORK – August 18, 2025 – Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced the launch of WahajPeak (the “Platform”), Stonepeak’s inaugural renewable energy platform in the Middle East dedicated to securing and developing high-quality renewable energy projects in the region and beyond.

Continue reading Stonepeak Launches Middle East Renewables Platform WahajPeak

Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity

In ATTAIN-1, the investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies at 72 weeks

Orforglipron achieved the primary and all key secondary endpoints, including demonstrating improvements in a number of cardiovascular risk factors

With these results, Lilly is on track to submit orforglipron to global regulatory agencies by year-end and is making substantial investments to meet anticipated demand at launch

Continue reading Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity

Sunmarke School Celebrates Record-Breaking A-Level And BTEC Results – Reaffirming Its Place Among The UAE’s Top Schools

DUBAI, United Arab Emirates, 14th August 2025 – Sunmarke School is proud to announce another year of outstanding A-Level and BTEC Level 3 results, marking its ninth consecutive year of academic excellence and strengthening the school’s reputation as one of the UAE’s leading providers of world-class education.

Continue reading Sunmarke School Celebrates Record-Breaking A-Level And BTEC Results – Reaffirming Its Place Among The UAE’s Top Schools